Study S001882

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Through an Individualized Nutritionnal Approach and Semaglutide Therapy.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06764056
Acronym: METAfoie
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 120
Start: 2025-01
Primary completion: 2026-05
Lead sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
Conditions: Metabolic Associated Fatty Liver Disease; Metabolic Associated-dysfunction Steatohepatitis (MASH); Obesity
Interventions: DRUG:semaglutide; OTHER:Diet
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Liver Steatosis [From enrollment to the end of the clinical trial at 12 months (for 4 visits)]
Liver Stiffness [From enrollment to the end of the clinical trial at 12 months (for 4 visits)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.